Resources from the same session
Minimising the toxicities of targeted therapies
Presenter: Thomas Bachelot
Session: New developments in the management of ER-positive metastatic breast cancer
Resources:
Presentation
Unlocking the pathways of endocrine resistance
Date
07 Oct 2016Session
New developments in the management of ER-positive metastatic breast cancerPresenters
Giuseppe CuriglianoAuthors
G. CuriglianoAuthor affiliations
- Drug Development, Istituto Europeo di Oncologia, 20141 - Milano/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.